State Street Corporation 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 1:20 pm Sale |
2022-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
STATE STREET CORP STT |
337,491 1.950% |
-50,315 (-12.97%) |
Filing |
| 2022-10-11 2:06 pm Sale |
2022-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
STATE STREET CORP STT |
387,807 2.240% |
-2,006,750 (-83.80%) |
Filing |
| 2022-07-11 11:46 am Purchase |
2022-06-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
STATE STREET CORP STT |
2,394,557 13.920% |
1,537,976 (+179.55%) |
Filing |
| 2022-02-11 7:55 pm Sale |
2021-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
STATE STREET CORP STT |
856,581 5.010% |
-79,669 (-8.51%) |
Filing |
| 2021-02-11 07:18 am Purchase |
2020-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
STATE STREET CORP STT |
936,250 5.540% |
936,250 (New Position) |
Filing |